Abiraterone acetate plus prednisone versus prednisone alone in chemotherapy-naive men with metastatic castration-resistant prostate cancer: patient-reported …

E Basch, K Autio, CJ Ryan, P Mulders, N Shore… - The lancet …, 2013 - thelancet.com
Background Abiraterone acetate plus prednisone significantly improves radiographic
progression-free survival in asymptomatic or mildly symptomatic, chemotherapy-naive …
被引用次数：206 相关文章

Abiraterone acetate plus prednisone versus prednisone alone in chemotherapy-naive men with metastatic castration-resistant prostate cancer: patient-reported …

E Basch, K Autio, CJ Ryan, P Mulders, N Shore… - cancer, 2013 - thelancet.com
Background Abiraterone acetate plus prednisone significantly improves radiographic
progression-free survival in asymptomatic or mildly symptomatic, chemotherapy-naive …

Abiraterone acetate plus prednisone versus prednisone alone in chemotherapy-naive men with metastatic castration-resistant prostate cancer: patient-reported …

E Basch, K Autio, CJ Ryan, P Mulders, N Shore… - The Lancet …, 2013 - infona.pl
Abiraterone acetate plus prednisone significantly improves radiographic progression-free
survival in asymptomatic or mildly symptomatic, chemotherapy-naive patients with metastatic …

[引用][C] Abiraterone acetate plus prednisone versus prednisone alone in chemotherapy-naive men with metastatic castration-resistant prostate cancer: patient-reported …

E Basch, K Autio, CJ Ryan, PFA Mulders, N Shore… - 2013 - repository.ubn.ru.nl
BACKGROUND: Abiraterone acetate plus prednisone significantly improves radiographic
progression-free survival in asymptomatic or mildly symptomatic, chemotherapy-naive …

Abiraterone acetate plus prednisone versus prednisone alone in chemotherapy-naive men with metastatic castration-resistant prostate cancer: patient-reported …

E Basch, K Autio, CJ Ryan, P Mulders, N Shore… - The Lancet …, 2013 - europepmc.org
Background Abiraterone acetate plus prednisone significantly improves radiographic
progression-free survival in asymptomatic or mildly symptomatic, chemotherapy-naive …

Abiraterone acetate plus prednisone versus prednisone alone in chemotherapy-naive men with metastatic castration-resistant prostate cancer: Patient-reported …

E Basch, K Autio, CJ Ryan, P Mulders… - The Lancet …, 2013 - experts.umn.edu
Background: Abiraterone acetate plus prednisone significantly improves radiographic
progression-free survival in asymptomatic or mildly symptomatic, chemotherapy-naive …

Abiraterone acetate plus prednisone versus prednisone alone in chemotherapy-naive men with metastatic castration-resistant prostate cancer: patient-reported …

E Basch, K Autio, CJ Ryan, P Mulders… - The Lancet …, 2013 - pubmed.ncbi.nlm.nih.gov
Background Abiraterone acetate plus prednisone significantly improves radiographic
progression-free survival in asymptomatic or mildly symptomatic, chemotherapy-naive …

Abiraterone acetate plus prednisone versus prednisone alone in chemotherapy-naive men with metastatic castration-resistant prostate cancer: patient-reported …

E Basch, K Autio, CJ Ryan, P Mulders, N Shore… - The Lancet …, 2013 - Elsevier
Background Abiraterone acetate plus prednisone significantly improves radiographic
progression-free survival in asymptomatic or mildly symptomatic, chemotherapy-naive …

Abiraterone acetate plus prednisone versus prednisone alone in chemotherapy-naive men with metastatic castration-resistant prostate cancer: Patient-reported …

E Basch, K Autio, CJ Ryan… - The lancet …, 2013 - mdanderson.elsevierpure.com
Background: Abiraterone acetate plus prednisone significantly improves radiographic
progression-free survival in asymptomatic or mildly symptomatic, chemotherapy-naive …

[引用][C] Abiraterone acetate plus prednisone versus prednisone alone in chemotherapy-naive men with metastatic castration-resistant prostate cancer: patient-reported …

E Basch, K Autio, CJ Ryan, P Mulders, N Shore… - Lancet …, 2013 - Elsevier Limited